Benign neoplasm: Endocrine pancreas

pancreatic neuroendocrine tumor: Pancreatic endocrine tumor, also known as pancreatic neuroendocrine tumor (PNET), describes a group of endocrine tumors originating in the pancreas that are usually indolent and benign, but may have the potential to be malignant. They can be functional, exhibiting a hormonal hypersecretion syndrome, but can be non-functional presenting with non-specific symptoms and include insulinoma, glucagonoma, VIPoma, somatostatinoma (SSoma), PPoma and Zollinger-Ellison syndrome (ZES, or gastrinoma) and other ectopic hormone producing tumors (such as GRFoma) (see these terms).

Endpoint definition

↥
FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries Inpat., Oupat., Death

Hospital Discharge: ICD-10 D13.7&
Hospital discharge: ICD-9 2117
Cause of death: ICD-10 D13.7&
Cause of death: ICD-9 2117

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector CD2_BENIGN_ENDOCRINE_PANCREAS

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D13
Name in latin Neoplasma benignum partis endocrinae pancreatis

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 73 30 43
Unadjusted prevalence (%) 0.03 0.02 0.04
Mean age at first event (years) 60.18 54.50 64.14

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

↥

Index endpoint: CD2_BENIGN_ENDOCRINE_PANCREAS – Benign neoplasm: Endocrine pancreas
GWS hits:

Survival analyses between endpoints

↥

Plot

before Benign neoplasm: Endocrine pancreas
after Benign neoplasm: Endocrine pancreas

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Benign neoplasm: Endocrine pancreas

↥